Department of Paediatrics & Child Health, University of Ilorin and University of Ilorin Teaching Hospital, Ilorin, Kwara State, Nigeria.
Department of Paediatrics, Gombe State University & Federal Teaching Hospital Gombe, Gombe, Gombe State, Nigeria.
PLoS One. 2024 May 16;19(5):e0303323. doi: 10.1371/journal.pone.0303323. eCollection 2024.
Despite the huge burden of sickle cell disease (SCD) among Nigerian children, the burden and outcome of respiratory illnesses remain undocumented. Thus, we aimed to describe the spectrum and outcome of respiratory illnesses among SCD childrenand adolescentadmissions in ten Nigerian tertiary hospitals.
A retrospective review of the SCD admission records of children and adolescents with a confirmed diagnosis of respiratory illnesses from 2012 to 2021 in ten tertiary health facilities across five geopolitical zones in Nigeria was conducted. The data, collectedbetween March and June 2023, included the age, sex, diagnosis, complications, duration and outcome of hospitalization.
Of the 72,333 paediatric admissions, 7,256 (10.0%) had SCD; the proportion of SCD from the total admission ranged from 2.1 to 16.3% in the facilities. Of the 7,256 children and adolescents with SCD, 1,213 (16.7%) had respiratory morbidities. Lower respiratory disease was the most common (70.0%) respiratory entity and the majority were pneumonia (40.1.0%), followed by acute chest syndrome (26.7%). Seventeen (1.4%) patients died; all had lower respiratory diseases [(acute chest syndrome ACS (11, 64.7%), pneumonia; 5, 29.4%, and asthma (1, 5.9%). Based on the proportion of deaths among overall SCD, the 17 death cases contributed 9.4% (95% CI 5.9 to 14.5). Factors associated with deaths included duration of hospitalization less than 72 hours and lower respiratory tract diseases.
Sickle cell disease is a major contributor to hospitalization among Nigerian children and adolescents, with high respiratory morbidity and mortality. Pneumonia and acute chest syndrome were associated with mortality, andthe highest risk of death within the first 72 hours.
尽管尼日利亚儿童患镰状细胞病(SCD)的负担巨大,但呼吸系统疾病的负担和结果仍未记录在案。因此,我们旨在描述 10 家尼日利亚三级医院 SCD 患儿和青少年住院患者呼吸系统疾病的谱和结果。
对 2012 年至 2021 年期间在尼日利亚五个地理区域的 10 家三级医疗机构中确诊患有呼吸系统疾病的 SCD 儿童和青少年的 SCD 住院记录进行了回顾性审查。数据收集于 2023 年 3 月至 6 月期间,包括年龄、性别、诊断、并发症、住院时间和结局。
在 72333 例儿科住院患者中,7256 例(10.0%)患有 SCD;各医疗机构的 SCD 总住院比例从 2.1%到 16.3%不等。在 7256 例患有 SCD 的儿童和青少年中,1213 例(16.7%)有呼吸系统疾病。下呼吸道疾病是最常见的(70.0%)呼吸系统实体,其中大多数是肺炎(40.1.0%),其次是急性胸部综合征(26.7%)。有 17 例(1.4%)患者死亡;所有患者均患有下呼吸道疾病[急性胸部综合征 ACS(11 例,64.7%)、肺炎(5 例,29.4%)和哮喘(1 例,5.9%)]。根据 SCD 总死亡率中的死亡比例,这 17 例死亡病例占 9.4%(95%CI 5.9%至 14.5%)。与死亡相关的因素包括住院时间少于 72 小时和下呼吸道疾病。
SCD 是尼日利亚儿童和青少年住院的主要原因,呼吸系统发病率和死亡率高。肺炎和急性胸部综合征与死亡率相关,死亡风险最高发生在住院的前 72 小时内。